A study published in the Journal of Primary Care & Community Health showed that patients with hepatitis C virus treated at health facilities that served American Indian/Alaska Natives had better outcomes when the clinics collaborated with pharmacists. The study demonstrated that interdisciplinary teamwork improved outcomes in this at-risk and disadvantaged group. This could serve as
The U.S. Department of Veterans Affairs (VA) has developed models of care that can be used to reduce the overall burden of hepatitis C virus (HCV) infection. More than 92,000 veterans with HCV have been treated by the VA since January 2014. Their cure rates have exceeded 90 percent. Expansion of treatment capacity through
The risk of becoming infected with the hepatitis C virus is 39% higher for women who inject drugs compared with their male counterparts, according to findings published in the journal Clinical Infectious Diseases. The study evaluated data from seven studies on HIV and HCV involving 1,868 people in the US, Australia and Europe who inject
Recently approved direct-acting antiviral (DAA) regimens can safely and effectively treat hepatitis C without interferon, with cure rates often exceeding 95%, according to a recently published review. “Oral DAA regimens that are highly efficacious, well-tolerated, and relatively short in duration are now available for all [hepatitis C virus] genotypes and for patient populations historically considered
